VolitionRx Ltd
VNRX
16 hedge funds and large institutions have $23.9M invested in VolitionRx Ltd in 2016 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 4 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
147% more capital invested
Capital invested by funds: $9.66M → $23.9M (+$14.2M)
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
7% more funds holding
Funds holding: 15 → 16 (+1)
0.3% more ownership
Funds ownership: 0.66% → 0.95% (+0.3%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIM
Lagoda Investment Management
New York
|
+$5.07M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$149K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$145K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$91.3K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$52.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$61K |
| 2 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$38K |
| 3 |
Bank of New York Mellon
New York
|
-$32K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$10.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |
VNRX Hedge Fund Activity: Q3 2016 in Review
16 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q3 2016, worth a combined $23.9M — up 147% from $9.66M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new VNRX positions and 4 closed out — a net gain of 1 holder — while 6 added to existing stakes and 1 trimmed.
The largest buyer was Lagoda Investment Management, adding an estimated $5.07M. The largest seller was Goldman Sachs, exiting entirely with an estimated $61K sold.
- 16 institutional investors held VolitionRx Ltd (VNRX) as of Q3 2016, up from 15 in Q2 2016.
- Funds reported $23.9M of VolitionRx Ltd stock for Q3 2016, up 147% quarter-over-quarter.
- 5 funds opened new VolitionRx Ltd positions in Q3 2016 and 4 closed out, a net change of +1 holder.
- The largest VolitionRx Ltd buyer in Q3 2016 was Lagoda Investment Management, an estimated $5.07M added.
- The largest VolitionRx Ltd seller in Q3 2016 was Goldman Sachs, an estimated $61K sold.
Based on aggregated 13F filings for Q3 2016.